Clinical Trial Update: Simvastatin to Prevent SCI-Induced Bone Loss [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating simvastatin to prevent bone loss after spinal cord injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Spinal Cord Injuries

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Craig Hospital | Conditions: Spinal Cord Injuries, Osteoporosis | Phase 2 | Status: UNKNOWN